Changes in Myocardial Perfusion During Chronic Multi Site Biventricular Versus Right Ventricular Apex Pacing in Patients With Normal Left Ventricular Function Undergoing His Bundle Ablation for Drug-refractory Atrial Fibrillation (SOS)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2010 by R&D Cardiologie.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
R&D Cardiologie
Information provided by:
R&D Cardiologie
ClinicalTrials.gov Identifier:
NCT00528307
First received: September 11, 2007
Last updated: June 9, 2010
Last verified: June 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To determine whether Biventricular pacing in patients undergoing HIS bundle ablation for atrial fibrilation has beneficial effects on myocardial perfusion and left ventricularr ejection fraction.
| Condition | Intervention |
|---|---|
|
Atrial Fibrillation |
Device: HIS buldle ablation |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Crossover Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Changes in Myocardial Perfusion During Chronic Multi Site Biventricular Versus Right Ventricular Apex Pacing in Patients With Normal Left Ventricular Function Undergoing His Bundle Ablation for Drug-refractory Atrial Fibrillation |
Resource links provided by NLM:
Genetics Home Reference related topics:
familial atrial fibrillation
MedlinePlus related topics:
Atrial Fibrillation
U.S. FDA Resources
Further study details as provided by R&D Cardiologie:
Primary Outcome Measures:
- Difference in size of myocardial perfusion abnormalities in the two treatment groups as measured with MPS. [ Time Frame: 6 months ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 30 |
| Study Start Date: | October 2007 |
| Estimated Study Completion Date: | December 2010 |
| Estimated Primary Completion Date: | July 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: 1
First 3 months of biventricular pacing, second 3 months right ventricular apical pacing
|
Device: HIS buldle ablation
HIS bundle ablation, followed by implant of a biventricular pacemaker
|
|
Active Comparator: 2
First 3 months of right ventricular apical pacing, second 3 months biventricular pacing
|
Device: HIS buldle ablation
HIS bundle ablation, followed by implant of a biventricular pacemaker
|
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Normal to nearly normal LVF (EF > 40%)
- Drug-refractory, persistent or permanent atrial fibrillation
- Referred for His ablation
Exclusion Criteria:
- Unwilling or unable to sign the informed consent
- Life expectancy < 1year from non-cardiac causes
- Previous myocardial infarction
- Previous coronary bypass surgery
- Poor left ventricle function (EF< 40%) from any cause
- Symptomatic obstructive coronary artery disease
- Poor ultra sound imaging quality.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00528307
Locations
| Netherlands | |
| St Antonius Hospital | Recruiting |
| Nieuwegein, Utrecht, Netherlands, 3435CM | |
| Contact: Lucas VA Boersma, MD, PhD +31 30 6092278 v.van.dijk@antonius.net | |
| Principal Investigator: Lucas VA Boersma, MD, PhD | |
Sponsors and Collaborators
R&D Cardiologie
Investigators
| Principal Investigator: | Lucas VA Boersma, MD, PHD | St. Antonius Hospital |
More Information
No publications provided
| Responsible Party: | Lucas VA Boersma, MD PhD, St Antonius Hospital |
| ClinicalTrials.gov Identifier: | NCT00528307 History of Changes |
| Other Study ID Numbers: | RDC-2006-03 |
| Study First Received: | September 11, 2007 |
| Last Updated: | June 9, 2010 |
| Health Authority: | Netherlands: The Central Committee on Research Involving Human Subjects (CCMO) |
Keywords provided by R&D Cardiologie:
|
myocardial perfusion His ablation biventricular pacing His bundle ablation for atrial fibrillation |
Additional relevant MeSH terms:
|
Atrial Fibrillation Arrhythmias, Cardiac Heart Diseases Cardiovascular Diseases Pathologic Processes |
ClinicalTrials.gov processed this record on May 16, 2013